---
figid: PMC6358886__ijms-20-00412-g002
figlink: /pmc/articles/PMC6358886/figure/ijms-20-00412-f002/
number: F2
caption: PI3K pathway inhibitors target one or more aspects of PI3K signaling. PKI-587
  and BEZ235 are dual PI3K/mTOR inhibitors. ZSTK-474 is a pan-PI3K inhibitor. Idelalisib
  and PI3K-IN-015 are each targeting PI3Kdelta isoforms. Duvelisib is a dual PI3K
  gamma/delta inhibitor. SF2535 is a novel PI3Kdelta/BRD4 inhibitor. → = Include  =
  Activation  = Inhibition.
pmcid: PMC6358886
papertitle: Targeting PI3K Signaling in Acute Lymphoblastic Leukemia.
reftext: Vanessa Edna Sanchez, et al. Int J Mol Sci. 2019 Jan;20(2):412.
pmc_ranked_result_index: '48097'
pathway_score: 0.9181484
filename: ijms-20-00412-g002.jpg
figtitle: PI3K pathway inhibitors target one or more aspects of PI3K signaling
year: '2019'
organisms: Homo sapiens
ndex: 174578fc-debf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6358886__ijms-20-00412-g002.html
  '@type': Dataset
  description: PI3K pathway inhibitors target one or more aspects of PI3K signaling.
    PKI-587 and BEZ235 are dual PI3K/mTOR inhibitors. ZSTK-474 is a pan-PI3K inhibitor.
    Idelalisib and PI3K-IN-015 are each targeting PI3Kdelta isoforms. Duvelisib is
    a dual PI3K gamma/delta inhibitor. SF2535 is a novel PI3Kdelta/BRD4 inhibitor.
    → = Include  = Activation  = Inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - SERPINB6
  - AKT3
  - BRD4
  - AKT2
  - PIK3CB
  - PIK3CD
  - AKT1
  - PIK3R4
  - PIK3R5
  - PIK3CG
  - PIK3R3
  - PIK3CA
  - PIK3R6
  - ZSTK-474
  - PKI-587
  - BEZ235
genes:
- word: mTor
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3KY/6
  symbol: PI6
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINB6
  entrez: '5269'
- word: p-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Brd4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: p-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: p-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: ZSTK-474
  source: MESH
  identifier: C510150
- word: PKI-587
  source: MESH
  identifier: C549060
- word: BEZ235
  source: MESH
  identifier: C531198
diseases: []
figid_alias: PMC6358886__F2
redirect_from: /figures/PMC6358886__F2
figtype: Figure
---
